| ENSG00000197299 |
BLM |
colorectal adenocarcinoma |
sequence_alteration |
3.38% (41/1213) |
1 entry |
| ENSG00000197299 |
BLM |
breast ductal adenocarcinoma |
missense_variant |
3.413% (54/1582) |
1 entry |
| ENSG00000197299 |
BLM |
breast ductal adenocarcinoma |
stop_gained |
3.413% (54/1582) |
1 entry |
| ENSG00000197299 |
BLM |
hemangioblastoma |
sequence_alteration |
17.14% (6/35) |
1 entry |
| ENSG00000197299 |
BLM |
esophageal adenocarcinoma |
missense_variant |
4.587% (25/545) |
1 entry |
| ENSG00000197299 |
BLM |
colorectal adenocarcinoma |
missense_variant |
3.38% (41/1213) |
3 entries |
| ENSG00000197299 |
BLM |
esophageal adenocarcinoma |
sequence_alteration |
4.587% (25/545) |
1 entry |
| ENSG00000197299 |
BLM |
breast ductal adenocarcinoma |
sequence_alteration |
3.413% (54/1582) |
1 entry |
| ENSG00000197299 |
BLM |
colorectal adenocarcinoma |
frameshift_variant |
3.38% (41/1213) |
3 entries |
| ENSG00000197299 |
BLM |
gastric adenocarcinoma |
frameshift_variant |
1.43% (12/839) |
2 entries |
| ENSG00000197299 |
BLM |
bladder carcinoma |
missense_variant |
3.03% (17/561) |
1 entry |
| ENSG00000197299 |
BLM |
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
2.322% (15/646) |
1 entry |
| ENSG00000197299 |
BLM |
colon adenocarcinoma |
sequence_alteration |
2.169% (28/1291) |
2 entries |
| ENSG00000197299 |
BLM |
lung adenocarcinoma |
frameshift_variant |
1.28% (33/2579) |
1 entry |
| ENSG00000197299 |
BLM |
clear cell renal carcinoma |
sequence_alteration |
0.6949% (11/1583) |
2 entries |
| ENSG00000197299 |
BLM |
clear cell renal carcinoma |
missense_variant |
0.6949% (11/1583) |
1 entry |
| ENSG00000197299 |
BLM |
skin melanoma |
sequence_alteration |
1.984% (23/1159) |
2 entries |
| ENSG00000197299 |
BLM |
squamous cell lung carcinoma |
missense_variant |
1.005% (10/995) |
1 entry |
| ENSG00000197299 |
BLM |
pancreatic ductal adenocarcinoma |
missense_variant |
2.319% (39/1682) |
1 entry |
| ENSG00000197299 |
BLM |
prostate adenocarcinoma |
missense_variant |
2.316% (51/2202) |
2 entries |
| ENSG00000197299 |
BLM |
Merkel cell skin cancer |
missense_variant |
3.226% (3/93) |
2 entries |
| ENSG00000197299 |
BLM |
colorectal adenocarcinoma |
stop_gained |
3.38% (41/1213) |
1 entry |
| ENSG00000197299 |
BLM |
esophageal squamous cell carcinoma |
missense_variant |
1.316% (9/684) |
2 entries |
| ENSG00000197299 |
BLM |
melanoma |
conservative_inframe_deletion |
4.828% (7/145) |
1 entry |
| ENSG00000197299 |
BLM |
esophageal adenocarcinoma |
frameshift_variant |
4.587% (25/545) |
1 entry |
| ENSG00000197299 |
BLM |
squamous cell lung carcinoma |
sequence_alteration |
1.005% (10/995) |
2 entries |
| ENSG00000197299 |
BLM |
lobular breast carcinoma |
missense_variant |
3.896% (9/231) |
1 entry |
| ENSG00000197299 |
BLM |
lung adenocarcinoma |
missense_variant |
1.28% (33/2579) |
6 entries |
| ENSG00000197299 |
BLM |
small cell lung carcinoma |
sequence_alteration |
0.8969% (4/446) |
2 entries |
| ENSG00000197299 |
BLM |
cecum adenocarcinoma |
missense_variant |
4.833% (13/269) |
2 entries |
| ENSG00000197299 |
BLM |
colon adenocarcinoma |
frameshift_variant |
2.169% (28/1291) |
3 entries |
| ENSG00000197299 |
BLM |
urothelial carcinoma |
missense_variant |
5.814% (5/86) |
1 entry |
| ENSG00000197299 |
BLM |
breast carcinoma |
missense_variant |
0.8141% (12/1474) |
1 entry |
| ENSG00000197299 |
BLM |
basal cell carcinoma |
sequence_alteration |
10.29% (7/68) |
1 entry |
| ENSG00000197299 |
BLM |
skin melanoma |
missense_variant |
1.984% (23/1159) |
4 entries |
| ENSG00000197299 |
BLM |
lung adenocarcinoma |
sequence_alteration |
1.28% (33/2579) |
3 entries |
| ENSG00000197299 |
BLM |
prostate carcinoma |
sequence_alteration |
2.479% (12/484) |
2 entries |
| ENSG00000197299 |
BLM |
Endometrial Endometrioid Adenocarcinoma |
frameshift_variant |
2.322% (15/646) |
1 entry |
| ENSG00000197299 |
BLM |
pancreatic ductal adenocarcinoma |
sequence_alteration |
2.319% (39/1682) |
1 entry |
| ENSG00000197299 |
BLM |
female breast carcinoma |
missense_variant |
1.023% (4/391) |
1 entry |
| ENSG00000197299 |
BLM |
esophageal squamous cell carcinoma |
sequence_alteration |
1.316% (9/684) |
1 entry |
| ENSG00000197299 |
BLM |
non-small cell lung carcinoma |
missense_variant |
3.81% (4/105) |
1 entry |
| ENSG00000197299 |
BLM |
nasopharyngeal squamous cell carcinoma |
frameshift_variant |
1.111% (2/180) |
2 entries |
| ENSG00000197299 |
BLM |
basal cell carcinoma |
missense_variant |
10.29% (7/68) |
1 entry |
| ENSG00000197299 |
BLM |
pharyngeal squamous cell carcinoma |
missense_variant |
3.704% (3/81) |
1 entry |
| ENSG00000197299 |
BLM |
cecum adenocarcinoma |
frameshift_variant |
4.833% (13/269) |
1 entry |
| ENSG00000197299 |
BLM |
small cell lung carcinoma |
missense_variant |
0.8969% (4/446) |
2 entries |
| ENSG00000197299 |
BLM |
melanoma |
missense_variant |
4.828% (7/145) |
2 entries |
| ENSG00000197299 |
BLM |
head and neck squamous cell carcinoma |
missense_variant |
0.6676% (5/749) |
2 entries |
| ENSG00000197299 |
BLM |
gastric adenocarcinoma |
missense_variant |
1.43% (12/839) |
1 entry |
| ENSG00000197299 |
BLM |
ovarian serous adenocarcinoma |
missense_variant |
0.6017% (5/831) |
2 entries |
| ENSG00000197299 |
BLM |
chronic lymphocytic leukemia |
missense_variant |
0.7856% (7/891) |
1 entry |
| ENSG00000197299 |
BLM |
diffuse large B-cell lymphoma |
missense_variant |
1.075% (4/372) |
2 entries |
| ENSG00000197299 |
BLM |
diffuse gastric adenocarcinoma |
missense_variant |
2.439% (2/82) |
2 entries |
| ENSG00000197299 |
BLM |
pleomorphic liposarcoma |
missense_variant |
22.22% (2/9) |
2 entries |
| ENSG00000197299 |
BLM |
gastric intestinal type adenocarcinoma |
frameshift_variant |
3.529% (3/85) |
1 entry |
| ENSG00000197299 |
BLM |
Gallbladder Adenocarcinoma |
missense_variant |
1.84% (3/163) |
2 entries |
| ENSG00000197299 |
BLM |
brain glioblastoma |
missense_variant |
0.495% (6/1212) |
2 entries |
| ENSG00000197299 |
BLM |
bladder transitional cell carcinoma |
missense_variant |
2.908% (13/447) |
3 entries |
| ENSG00000197299 |
BLM |
colon adenocarcinoma |
stop_gained |
2.169% (28/1291) |
1 entry |
| ENSG00000197299 |
BLM |
colon adenocarcinoma |
missense_variant |
2.169% (28/1291) |
4 entries |
| ENSG00000197299 |
BLM |
papillary thyroid carcinoma |
missense_variant |
0.6135% (3/489) |
2 entries |
| ENSG00000197299 |
BLM |
hepatocellular carcinoma |
missense_variant |
1.927% (19/986) |
1 entry |
| ENSG00000197299 |
BLM |
breast ductal adenocarcinoma |
frameshift_variant |
3.413% (54/1582) |
1 entry |
| ENSG00000197299 |
BLM |
rectal adenocarcinoma |
missense_variant |
0.9158% (5/546) |
2 entries |
| ENSG00000197299 |
BLM |
cecum adenocarcinoma |
sequence_alteration |
4.833% (13/269) |
1 entry |
| ENSG00000197299 |
BLM |
lung carcinoid tumor |
missense_variant |
3.704% (1/27) |
1 entry |
| ENSG00000197299 |
BLM |
ovarian serous adenocarcinoma |
sequence_alteration |
0.6017% (5/831) |
1 entry |
| ENSG00000197299 |
BLM |
ependymoma |
sequence_alteration |
1.852% (1/54) |
1 entry |
| ENSG00000197299 |
BLM |
ovarian serous adenocarcinoma |
frameshift_variant |
0.6017% (5/831) |
1 entry |
| ENSG00000197299 |
BLM |
head and neck squamous cell carcinoma |
sequence_alteration |
0.6676% (5/749) |
1 entry |
| ENSG00000197299 |
BLM |
adenosquamous lung carcinoma |
stop_gained |
4.545% (1/22) |
1 entry |
| ENSG00000197299 |
BLM |
HER2 Positive Breast Carcinoma |
missense_variant |
4.255% (8/188) |
1 entry |
| ENSG00000197299 |
BLM |
Adrenal Gland Neuroblastoma |
missense_variant |
1.667% (1/60) |
1 entry |
| ENSG00000197299 |
BLM |
gastric adenocarcinoma |
sequence_alteration |
1.43% (12/839) |
1 entry |
| ENSG00000197299 |
BLM |
pharyngeal squamous cell carcinoma |
stop_gained |
3.704% (3/81) |
1 entry |
| ENSG00000197299 |
BLM |
pancreatic neuroendocrine tumor |
missense_variant |
1.695% (4/236) |
1 entry |
| ENSG00000197299 |
BLM |
melanoma |
frameshift_variant |
4.828% (7/145) |
1 entry |
| ENSG00000197299 |
BLM |
Endometrial Clear Cell Adenocarcinoma |
missense_variant |
3.846% (1/26) |
1 entry |
| ENSG00000197299 |
BLM |
large cell lung carcinoma |
missense_variant |
5.263% (1/19) |
1 entry |
| ENSG00000197299 |
BLM |
Duodenal Adenocarcinoma |
missense_variant |
11.76% (2/17) |
1 entry |
| ENSG00000197299 |
BLM |
Gallbladder Adenocarcinoma |
stop_gained |
1.84% (3/163) |
1 entry |
| ENSG00000197299 |
BLM |
Duodenal Adenocarcinoma |
frameshift_variant |
11.76% (2/17) |
1 entry |
| ENSG00000197299 |
BLM |
T-cell acute lymphoblastic leukemia |
missense_variant |
0.1681% (1/595) |
1 entry |
| ENSG00000197299 |
BLM |
Breast Carcinoma by Gene Expression Profile |
frameshift_variant |
2.041% (1/49) |
1 entry |
| ENSG00000197299 |
BLM |
small intestinal adenocarcinoma |
frameshift_variant |
4.762% (1/21) |
1 entry |
| ENSG00000197299 |
BLM |
anaplastic astrocytoma |
frameshift_variant |
0.7634% (1/131) |
1 entry |
| ENSG00000197299 |
BLM |
oral squamous cell carcinoma |
missense_variant |
0.7605% (2/263) |
1 entry |
| ENSG00000197299 |
BLM |
basal cell carcinoma |
stop_gained |
10.29% (7/68) |
1 entry |
| ENSG00000197299 |
BLM |
urothelial carcinoma |
sequence_alteration |
5.814% (5/86) |
1 entry |
| ENSG00000197299 |
BLM |
medullary thyroid gland carcinoma |
frameshift_variant |
2.778% (1/36) |
1 entry |
| ENSG00000197299 |
BLM |
urothelial carcinoma |
conservative_inframe_deletion |
5.814% (5/86) |
1 entry |
| ENSG00000197299 |
BLM |
nasopharyngeal squamous cell carcinoma |
sequence_alteration |
1.111% (2/180) |
1 entry |
| ENSG00000197299 |
BLM |
gastric intestinal type adenocarcinoma |
missense_variant |
3.529% (3/85) |
1 entry |
| ENSG00000197299 |
BLM |
salivary gland adenoid cystic carcinoma |
missense_variant |
1.667% (1/60) |
1 entry |
| ENSG00000197299 |
BLM |
Unclassified Renal Cell Carcinoma |
missense_variant |
5.0% (1/20) |
1 entry |
| ENSG00000197299 |
BLM |
bladder transitional cell carcinoma |
stop_gained |
2.908% (13/447) |
1 entry |
| ENSG00000197299 |
BLM |
small intestinal adenocarcinoma |
sequence_alteration |
4.762% (1/21) |
1 entry |
| ENSG00000197299 |
BLM |
papillary renal cell carcinoma |
sequence_alteration |
0.2584% (1/387) |
1 entry |
| ENSG00000197299 |
BLM |
bile duct adenocarcinoma |
sequence_alteration |
0.2597% (1/385) |
1 entry |
| ENSG00000197299 |
BLM |
Ampulla of Vater Carcinoma |
missense_variant |
1.176% (1/85) |
1 entry |
| ENSG00000197299 |
BLM |
brain glioblastoma |
sequence_alteration |
0.495% (6/1212) |
1 entry |
| ENSG00000197299 |
BLM |
lung adenocarcinoma |
stop_gained |
1.28% (33/2579) |
1 entry |
| ENSG00000197299 |
BLM |
oral squamous cell carcinoma |
frameshift_variant |
0.7605% (2/263) |
1 entry |
| ENSG00000197299 |
BLM |
oral squamous cell carcinoma |
sequence_alteration |
0.7605% (2/263) |
1 entry |
| ENSG00000197299 |
BLM |
pancreatic ductal adenocarcinoma |
frameshift_variant |
2.319% (39/1682) |
1 entry |
| ENSG00000197299 |
BLM |
B-cell acute lymphoblastic leukemia |
missense_variant |
1.852% (1/54) |
1 entry |
| ENSG00000197299 |
BLM |
Cervical Adenosquamous Carcinoma |
missense_variant |
20.0% (1/5) |
1 entry |
| ENSG00000197299 |
BLM |
prostate carcinoma |
missense_variant |
2.479% (12/484) |
1 entry |
| ENSG00000197299 |
BLM |
prostate adenocarcinoma |
frameshift_variant |
2.316% (51/2202) |
1 entry |
| ENSG00000197299 |
BLM |
melanoma |
sequence_alteration |
4.828% (7/145) |
1 entry |
| ENSG00000197299 |
BLM |
bile duct adenocarcinoma |
missense_variant |
0.2597% (1/385) |
1 entry |